Search results for " Respiratory System"

showing 10 items of 851 documents

INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry

2021

Contains fulltext : 231528.pdf (Publisher’s version ) (Closed access) BACKGROUND: TNF receptor-associated periodic syndrome (TRAPS) is a rare autoinflammatory disease caused by dominant mutation of the TNF super family receptor 1A (TNFRSF1A) gene. Data regarding long-term treatment outcomes are lacking. OBJECTIVE: To assess correlations of genotype-phenotypes in patients with TRAPS, as defined by the International Study Group for Systemic Autoinflammatory Diseases (INSAID) classification and Eurofever criteria, with treatment responses. METHODS: Data from 226 patients with variants of the TNFRSF1A gene and enrolled in the Eurofever registry were classified according to the INSAID classifica…

medicine.medical_specialtyAbdominal painAutoinflammatory diseasesGroup AGroup BAA amyloidosis Anakinra Autoinflammatory diseases Colchicine TRAPS Abdominal Pain Colchicine FemaleHumans Mutation Registries Hereditary Autoinflammatory Diseases03 medical and health sciences0302 clinical medicineSettore MED/38 - Pediatria Generale E SpecialisticaAA amyloidosisTNF receptor-associated periodic syndrome (TRAPS) ; TNFRSF1A geneInternal medicinemedicineAA amyloidosisHumansImmunology and AllergyIn patientRegistries030212 general & internal medicineLikely pathogenicAnakinrabusiness.industryHereditary Autoinflammatory DiseasesTRAPSmedicine.diseaseAbdominal PainAnakinra030228 respiratory systemTNF receptor associated periodic syndromeMutationFemalemedicine.symptombusinessColchicineAA amyloidosis; Anakinra; Autoinflammatory diseases; Colchicine; TRAPSInflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5]medicine.drug
researchProduct

Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review

2017

Background Guidelines and position papers indicate that allergen immunotherapy (AIT) is the only disease-modifying treatment, including prevention of the onset of new allergen sensitizations. However, this preventive effect was shown by only a few observational studies. Our aim was to systematically review the efficacy of AIT in preventing the onset of new allergen sensitizations. Methods Computerized bibliographic searches of MEDLINE, EMBASE, and the Cochrane Library (through June 2015) were supplemented with manual searches of reference lists. Observational studies or randomized controlled trials with a long-term observation period were included. Paired reviewers extracted data about stud…

medicine.medical_specialtyAllergen immunotherapyImmunologyMEDLINECochrane Librarymedicine.disease_causePlacebolaw.invention03 medical and health sciences0302 clinical medicineAllergensystematic reviewRandomized controlled triallawInternal medicineHypersensitivityOdds RatiomedicineAnimalsHumansImmunology and Allergy030212 general & internal medicinebusiness.industryAbsolute risk reductionasthmaAllergensImmunoglobulin ErhinoconjunctivitiSurgeryGRADETreatment Outcome030228 respiratory systemDesensitization Immunologicallergen immunotherapyImmunizationObservational studybusinessAllergy
researchProduct

Helicobacter pylori Infection and Risk Factors in Relation to Allergy in Children

2017

Purpose To analyze presence of Helicobacter pylori infection and environmental risk factors among children with and without allergy. Methods Parents of children at primary health care centres/kindergartens and allergologist consultation were asked to answer a questionnaire and to bring a faecal sample. H. pylori infection was detected by monoclonal stool antigen test. Prevalence of H. pylori infection and risk factors were compared between individuals with and without allergy using χ2 test, ANOVA test and parameters and logistic regression. Results Among 220 children (mean age, 4.7 years; ±standard deviation 2.3 years) H. pylori positivity was non-significantly lower among patients with all…

medicine.medical_specialtyAllergyAllergymedicine.medical_treatmentLogistic regression03 medical and health sciences0302 clinical medicineInternal medicineMedicineCaesarean section030212 general & internal medicineFamily historyHepatologybiologyHelicobacter pyloribusiness.industryGastroenterologyOdds ratioHelicobacter pylorimedicine.diseasebiology.organism_classificationConfidence interval030228 respiratory systemRisk factorsPediatrics Perinatology and Child HealthOriginal ArticlebusinessBreast feedingPediatric Gastroenterology, Hepatology & Nutrition
researchProduct

Feasibility of the Allergy Questionnaire for Athletes (AQUA © ) in pediatric age

2018

A burden of respiratory and allergic symptoms up to almost 60% has been observed in young and adult athletes, influencing physical performances1 . The Allergy Questionnaire for Athletes (AQUA©) is a validated screening tool for the prediction of the atopic status in adult athletes2 ; it was recently tested in Belgian young elite athletes (12-14 years old)3 , but its actual feasibility and suitability for children and adolescent was not evaluated. Indeed, there is evidence that children are prone to employ "satisficing" response strategies, answering every question positively/negatively, or simply not answering4 . Therefore, the present cross-sectional survey was carried out to assess feasib…

medicine.medical_specialtyAllergyCross-sectional studyself-reports.ImmunologyMEDLINEAtopy03 medical and health sciences0302 clinical medicinemedicineImmunology and Allergy030212 general & internal medicineAsthmayoung athletesSettore M-EDF/02 - Metodi E Didattiche Delle Attivita' SportivebiologyAthletesbusiness.industrySettore MED/09 - MEDICINA INTERNAAQUA© questionnaireAdolescent; Athletes; Child; Cross-Sectional Studies; Feasibility Studies; Female; Humans; Hypersensitivity; Male; Sports; Surveys and Questionnaires; Pediatrics Perinatology and Child Health; Immunology and Allergy; ImmunologyPediatric ageself-reportsmedicine.diseasebiology.organism_classification030228 respiratory systemFamily medicinePediatrics Perinatology and Child Healthallergy symptoms AQUA© questionnaire feasibility linguistic adaptation young athletes missing answers self-reports.businessSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' Motorieallergy symptomsfeasibilityPediatric Allergy and Immunology
researchProduct

Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SA…

2021

The main contraindication to the anti-SARS CoV2 vaccine is an anaphylactic reaction to a vaccine component. The need to vaccinate allergic people who are at higher risk can be of public health interest and this report shows a case of an allergic reaction to PEG of a HCW who had received the first dose of anti-SARS CoV2 vaccine. For 5 h after the administration of the vaccine, she had the appearance of erythematous spots on the face and neck, and a feeling of a slurred mouth and hoarseness. In order to treat the event, she was administered 8 mg intravenous dexamethasone, 1 vial intravenous chlorphenamine maleate, 250 mL intravenous 0.9% NaCl, and conventional oxygen therapy (2 L/min) with co…

medicine.medical_specialtyAllergyImmunologyadverse reactionCase ReportVial03 medical and health sciences0302 clinical medicineInternal medicinevaccineDrug DiscoverymedicineanaphylaxisPharmacology (medical)030212 general & internal medicineAdverse effectContraindicationDexamethasonePharmacologym-RNA vaccinebusiness.industrySARS CoV2Rmedicine.diseasePEGAdverse reaction Anaphylaxis Basophil activation test Contraindica-tion M-RNA vaccine PEG SARS CoV2 VaccineVaccinationInfectious Diseases030228 respiratory systembasophil activation testMedicinebusinessAnaphylaxisAdverse drug reactioncontraindicationmedicine.drugVaccines
researchProduct

The geriatric asthma: pitfalls and challenges

2016

Historically, asthma has been envisioned as a disease of younger ages. This has led to the assumption that respiratory symptoms suggestive of asthma occurring in older ages are to be attributed to conditions other than asthma, mainly COPD. Old observational reports and new epidemiological studies confirm that asthma is as frequent in older as it is in younger populations. Nevertheless, under-recognition, misdiagnosis and under-treatment are still relevant issues. The characterization of asthma in the aged suffers from the fact that there has been very little original research in this field. Indeed, geriatric asthma is often excluded from clinical trials because of age and comorbidities. The…

medicine.medical_specialtyAllergyReviewDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioBiochemistryComorbiditiesPulmonary function testing03 medical and health sciences0302 clinical medicineimmune system diseasesEpidemiologymedicineAirflow obstructionaged asthma lung function comorbiditiesSenile lung030212 general & internal medicineIntensive care medicineAsthmaCOPDbusiness.industryOrganic Chemistrymedicine.diseaserespiratory tract diseasesClinical trial030228 respiratory systemLung function testsObservational studybusinessGeriatric asthmaAsthma Research and Practice
researchProduct

Fractional exhaled nitric oxide is associated with more severe asthma

2018

Fractional exhaled nitric oxide (FeNO) levels are used as a marker of airway inflammation. The aim of the present work was to evaluate a possible relationship between FeNO and parameters of asthma control and severity in different asthma phenotypes. FeNO was evaluated in 200 asthma patients (37% male, mean age ± SD 54±15 years, 19% controlled (GINA), 30% treated with oral corticosteroids (OCS), median FEV1 (interquartile range) 2,05 L (1,49-2,70), 74% pred. (56-90%)), together with other asthma characteristics (lung function, asthma control, allergies, serum IgE, serum ECP, and blood eosinophils). Patients with poorly controlled asthma had significantly higher FeNO values (ACQ-5≥1.5 vs. 70%…

medicine.medical_specialtyAllergybiologybusiness.industrySevere asthmaAirway inflammationrespiratory systemImmunoglobulin Emedicine.diseaseGastroenterologySerum igerespiratory tract diseases03 medical and health sciences0302 clinical medicine030228 respiratory systemInterquartile rangeInternal medicineExhaled nitric oxidemedicinebiology.protein030212 general & internal medicinebusinessAsthmaMonitoring Airway Disease
researchProduct

Patógenos atípicos en pacientes hospitalizados con neumonía adquirida en la comunidad: una perspectiva mundial

2018

Abstract Background Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. Methods A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Ris…

medicine.medical_specialtyAtypical pathogensEpidemiologyPopulationSettore MED/10 - Malattie Dell'Apparato Respiratoriolcsh:Infectious and parasitic diseases03 medical and health sciences0302 clinical medicineMedical microbiologyCommunity-acquired pneumoniaInternal medicineEpidemiologyRisk Factors.Medicinelcsh:RC109-216030212 general & internal medicineeducationAged 80 and overeducation.field_of_studybusiness.industryIncidence (epidemiology)Atypical pathogenHealthcare-Associated PneumoniaChlamydophila pneumoniaemedicine.diseaseAntibiotic coverageCAPPneumoniaInfectious Diseases030228 respiratory systemLegionnaires' diseasebusinessResearch Article
researchProduct

Epidemiología de la transfusión sanguínea en los Servicios de Medicina Intensiva en España: «Transfusion Day»

2022

Objective To describe the transfusion practice in the ICUs in Spain, according to national and international recommendations (guidelines).DesignProspective, cross-sectional, multi-centre study.ScopeData collection was carried out by means of a questionnaire sent electronically to the Heads of Service of 111 ICUs in Spain.Participants1,448 patients were included, aged 61.8 (SD 15.7) years, 66.2% male, with an SOFA of 4.7 ± 3.8 and average stay of 10.62 ± 17.49 days.VariablesDemographic and clinical variables of the patients were collected, as well as variables related to the transfusion act.ResultsOf the 1,448 patients, 9.9% received al least one transfusion of any blood product, 3.7% fresh …

medicine.medical_specialtyBlood transfusionbusiness.industryAnemiamedicine.medical_treatmentHemodynamics030208 emergency & critical care medicineCritical Care and Intensive Care Medicinemedicine.disease03 medical and health sciencesRed blood cell0302 clinical medicinemedicine.anatomical_structure030228 respiratory systemBlood productInternal medicineEpidemiologyMedicinePlateletHemoglobinbusinessMedicina Intensiva
researchProduct

Hereditary angioedema: an update on causes, manifestations and treatment.

2019

Hereditary angioedema is a rare genetic disorder caused by deficiency of C1 esterase inhibitor (C1-INH) and characterized by recurrent episodes of severe swelling that affect the limbs, face, intestinal tract and airway. Since laryngeal oedema can be life-threatening as a result of asphyxiation, correct diagnosis and management of hereditary angioedema is vital. Hereditary angioedema attacks are mediated by bradykinin, the production of which is regulated by C1-INH. Hereditary angioedema therapy relies on treatment of acute attacks, and short- and long-term prophylaxis. Acute treatment options include C1-INH concentrate, icatibant and ecallantide. Self-administration of treatment is recomm…

medicine.medical_specialtyBradykinin03 medical and health sciences0302 clinical medicineimmune system diseasesmedicineHumanscardiovascular diseases030212 general & internal medicineskin and connective tissue diseasesHereditary Angioedema Types I and IIbusiness.industryGenetic disorderfood and beveragesGeneral Medicinemedicine.diseaseDermatologyC1 esterase030228 respiratory systemHereditary angioedemaFactor XIIDisease ProgressionQuality of LifeKallikreinsbusinessPeptidesComplement C1 Inhibitor ProteinBritish journal of hospital medicine (London, England : 2005)
researchProduct